Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.

about

The role of interventional radiology in the treatment of epiphora.

P2860

Q55233761-BED23D84-6003-4134-91AA-379F16A9ECC3

P2860

Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.

Item

http://www.wikidata.org/entity/Q36389582

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Intervention using a novel bio ...... imal duct obstruction disease.

@ast

Intervention using a novel bio ...... imal duct obstruction disease.

@en

type

Item

label

Intervention using a novel bio ...... imal duct obstruction disease.

@ast

Intervention using a novel bio ...... imal duct obstruction disease.

@en

prefLabel

Intervention using a novel bio ...... imal duct obstruction disease.

@ast

Intervention using a novel bio ...... imal duct obstruction disease.

@en

P1476

Intervention using a novel bio ...... rimal duct obstruction disease

@en

P2093

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Nan Xiang

http://www.w3.org/2001/XMLSchema#string

Rong Liu

http://www.w3.org/2001/XMLSchema#string

Weikun Hu

http://www.w3.org/2001/XMLSchema#string

Xinyuan Zhan

http://www.w3.org/2001/XMLSchema#string

P2860

Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density.

Poly-epsilon-caprolactone/hydroxyapatite for tissue engineering scaffold fabrication via selective laser sintering.

Double silicone tube intubation for the management of partial lacrimal system obstruction.

Does the timing of silicone tube removal following external dacryocystorhinostomy affect patients' symptoms?

A modified lacrimal sac implant for high-risk dacryocystorhinostomy.

Microbiologic trends and biofilm growth on explanted periorbital biomaterials: a 30-year review.

Novel pentablock copolymer (PLA-PCL-PEG-PCL-PLA) based nanoparticles for controlled drug delivery: Effect of copolymer compositions on the crystallinity of copolymers and in vitro drug release profile from nanoparticles.

Novel porous scaffolds of poly(lactic acid) produced by phase-separation using room temperature ionic liquid and the assessments of biocompatibility.

Pushed monocanalicular intubation: an alternative stenting system for the management of congenital nasolacrimal duct obstructions.

Evaluation of polyurethane nasolacrimal duct stents: in vivo studies in New Zealand rabbits.

P304

e0178679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0178679

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xin Guo

P577

2017-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28570687

http://www.w3.org/2001/XMLSchema#string

P921

biodegradation

P932

5453559

http://www.w3.org/2001/XMLSchema#string

Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.

about

P2860

P2860

Intervention using a novel biodegradable hollow stent containing polylactic acid-polyprolactone-polyethylene glycol complexes against lacrimal duct obstruction disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932